| Autor: |
Kanellopoulos JM; CNRS, I2BC, Université Paris-Saclay, Orsay, France., Delarasse C; Inserm, Sorbonne Université, CNRS, Institut de la Vision, Paris, France. |
| Jazyk: |
angličtina |
| Zdroj: |
Frontiers in cellular neuroscience [Front Cell Neurosci] 2019 Sep 04; Vol. 13, pp. 401. Date of Electronic Publication: 2019 Sep 04 (Print Publication: 2019). |
| DOI: |
10.3389/fncel.2019.00401 |
| Abstrakt: |
The purinergic receptor P2X7 is expressed in neural and immune cells known to be involved in neurological diseases. Its ligand, ATP, is a signaling molecule that can act as a neurotransmitter in physiological conditions or as a danger signal when released in high amount by damaged/dying cells or activated glial cells. Thus, ATP is a danger-associated molecular pattern. Binding of ATP by P2X7 leads to the activation of different biochemical pathways, depending on the physiological or pathological environment. The aim of this review is to discuss various functions of P2X7 in the immune and central nervous systems. We present evidence that P2X7 may have a detrimental or beneficial role in the nervous system, in the context of neurological pathologies: epilepsy, Alzheimer's disease, multiple sclerosis, amyotrophic lateral sclerosis, age-related macular degeneration and cerebral artery occlusion. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
